This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Sk Biopharmaceuticals Co., Ltd.. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2018
Title: The Innovative Mind of Hye-Kyung Min: Advancements in Gastrointestinal Pharmaceuticals
Introduction
Hye-Kyung Min, a notable inventor based in Daejeon, South Korea, has made significant contributions to the field of pharmaceuticals with a focused expertise in piperidine compounds. With a track record of five patents, Min's work is vital in the ongoing pursuit of innovative solutions for gastrointestinal diseases, revealing the depth of his commitment to improving health outcomes.
Latest Patents
Among Hye-Kyung Min’s most recent patents are groundbreaking developments involving piperidine compounds. These patents include pharmaceutical compositions that incorporate racemic or enantiomerically enriched piperidine compounds. The innovations essentially present new methods for treating gastrointestinal diseases in mammals, showcasing the potential for both therapeutic advancements and increased efficacy in patient care.
Career Highlights
Hye-Kyung Min is currently associated with SK Biopharmaceuticals Co., Ltd., a leading company in the biopharmaceutical sector. His tenure at the company has been marked by a consistent drive towards innovation, particularly in designing and developing pharmaceutical products that address specific healthcare challenges. His expertise continues to propel the company towards new frontiers in gastrointestinal health.
Collaborations
Throughout his career, Hye-Kyung Min has collaborated with esteemed colleagues, including Coo-Min Chung and Hyung-Jin Jun. These collaborations reflect a dynamic synergy that enhances the potential for innovative research and development, allowing for the sharing of ideas and expertise essential for creating impactful pharmaceutical solutions.
Conclusion
Hye-Kyung Min stands out as a key innovator in the pharmaceutical industry, with his work on piperidine compounds poised to revolutionize treatments for gastrointestinal conditions. As he continues to advance his research in collaboration with talented professionals, his contributions are sure to leave a lasting impact on the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile